1. Introduction {#sec1-ijerph-17-05505}
===============

Rheumatic heart disease (RHD) is the most common cause of acquired heart disease in children globally \[[@B1-ijerph-17-05505]\]. It is a sequela of acute rheumatic fever (ARF), caused by an abnormal immunological response to a group A streptococcal (GAS) pharyngitis \[[@B2-ijerph-17-05505]\] or impetigo \[[@B3-ijerph-17-05505]\]. Spontaneous resolution of ARF symptoms occurs in most cases over weeks to months; however, 50--75% will progress to the chronic valvopathy of RHD \[[@B1-ijerph-17-05505]\]. Most will develop RHD as a result of recurrent episodes of ARF, however, valve damage can occur after a single episode \[[@B4-ijerph-17-05505]\]. In Australia, time to disease progression has been shown to vary. Some 35% of Indigenous cases progress to RHD within two years and 61% within ten years of their first ARF episode \[[@B5-ijerph-17-05505]\]. Although the incidence rates of ARF and RHD substantially decreased in high-income countries during the 20th century \[[@B6-ijerph-17-05505]\], there remains a significant burden of disease in disadvantaged minority populations, including Aboriginal and Torres Strait Islander (hereafter respectfully, Indigenous) populations in Australia who have some of the highest ARF/RHD rates globally \[[@B1-ijerph-17-05505],[@B7-ijerph-17-05505]\].

Intramuscular benzathine penicillin G (BPG) is widely used as a secondary prophylaxis to prevent recurrences in ARF episodes and subsequent RHD \[[@B3-ijerph-17-05505],[@B8-ijerph-17-05505]\]. Previous studies have demonstrated a decrease in the rates of ARF recurrences by 87% to 96% \[[@B9-ijerph-17-05505]\] and reductions in complications associated with RHD with the regular administration of BPG \[[@B1-ijerph-17-05505],[@B10-ijerph-17-05505]\]. The World Health Organization (WHO) recommends that countries faced with high ARF/RHD rates have "adequate monitoring and surveillance, as an integrated component of national health systems responses" \[[@B2-ijerph-17-05505],[@B11-ijerph-17-05505]\]; for an overview of the evolution of ARF/RHD registers globally, see \[[@B12-ijerph-17-05505]\].

In Australia, both ARF and RHD are notifiable conditions in the Northern Territory (NT), Western Australia (WA), South Australia (SA) and Queensland (QLD), with the timing of the introduction of notification varying in these jurisdictions. In the remaining states and territories, ARF and RHD are only partially or not notifiable. In addition, jurisdiction-based ARF/RHD registers were established independently and at different times across the NT (1997), WA (2009), QLD (2006), SA (2010) and New South Wales (NSW) (2015). This resulted in different operational definitions and underlying data structures \[[@B10-ijerph-17-05505],[@B13-ijerph-17-05505]\]. In SA and NT, clinicians have the option to enter the data of patients diagnosed with ARF and RHD directly into the register, however, most opt to faxing and emailing the control programs \[[@B13-ijerph-17-05505]\]. In WA and QLD, clinicians do not have the ability to manually enter data into the registers, but complete a notification form instead \[[@B13-ijerph-17-05505]\]. This results in control program staff being heavily involved with manual data handling and case validation \[[@B13-ijerph-17-05505]\]. The Federal government has published two reports (2013 and 2017) summarizing data from the jurisdictional registers \[[@B14-ijerph-17-05505],[@B15-ijerph-17-05505]\]. No integrated, national register exists.

According to the Australian guidelines for ARF and RHD diagnosis (a modification of the Jones and WHO criteria), both ARF and RHD are to be considered as differential diagnosis when evaluating Indigenous children and adolescents with cardiac symptoms, and hospitalisation is required for all ARF episodes as soon as possible after symptom onset \[[@B10-ijerph-17-05505]\]. RHD cases can be expected to be hospitalised for case management, especially for RHD-associated complications. Thus, in theory most cases identified through ARF/RHD register records should appear in hospital administrative data, and vice versa. In practice, gaps in case ascertainment on the ARF/RHD registers may persist and additional data is required to obtain more complete data for determining the ARF/RHD burden.

The END RHD in Australia: Study of Epidemiology (ERASE) Project aims to provide the first quasi-national epidemiological profile of ARF/RHD using linked data from multiple data sources. Linked administrative data allows for the follow-up of cases across health system contacts and facilities over time, avoiding overestimation of diagnoses and caseloads. The project works closely with the End RHD Centre for Research Excellence \[[@B16-ijerph-17-05505]\] which has developed a strategy to remove RHD as a public health problem in the country. ERASE has assembled a linked dataset covering five jurisdictions (NSW, NT, QLD, SA, WA) to facilitate ARF/RHD epidemiological research in Australia \[[@B17-ijerph-17-05505],[@B18-ijerph-17-05505]\]. Pertinent to the current study, ARF and RHD case identification was based on probability-linked ARF/RHD register, hospital admission and death data.

The overall aim of this study is to evaluate case ascertainment in the Australian ARF/RHD registers by comparing register records to administrative hospital data. The specific objectives were to:(1)describe the characteristics of ARF/RHD cases ascertained in the ARF/RHD register data, hospital data and both sources,(2)quantify case ascertainment by the ARF/RHD registers by determining the proportion of hospitalised ARF/RHD cases found in the ARF/RHD register data,(3)investigate the agreement of ARF and RHD diagnosis dates recorded on ARF/RHD registers and in the hospital data, and(4)identify factors associated with hospitalised ARF/RHD cases not being notified and recorded on the ARF/RHD registers.

2. Materials and Methods {#sec2-ijerph-17-05505}
========================

2.1. Study Design and Data Sources {#sec2dot1-ijerph-17-05505}
----------------------------------

This is a validation study of case ascertainment based on ARF/RHD diagnoses recorded in two different case ascertainment systems, namely the register and administrative hospital records. The parent ERASE database identified ARF and RHD cases diagnosed in paediatric and adult populations in NT, SA, QLD, NSW and WA between July 2001 and June 2017. These five jurisdictions are home to 86% of the Australian Indigenous population (at 30 June 2016) \[[@B19-ijerph-17-05505]\]. Cases diagnosed outside their jurisdiction of residence were excluded, because we do not have access to cross-jurisdictionally linked data except for NT and SA. For the current study, ARF or RHD diagnoses had to be recorded in either data source (administrative hospital records or register) at least one calendar year following the establishment of a register in their jurisdiction of residence (NT from July 2001, SA from January 2013, QLD from January 2010 and WA from January 2011). Due to the NSW's register's recent inception, NSW data was not included. The study excluded foreign residents and patients with ARF/RHD diagnoses made before register establishment or outside an individual's jurisdiction of residence. Administrative hospital data included records from public and private hospitals (NT and SA public hospitals only).

An ARF episode was defined as an episode recorded on an ARF/RHD register or as the principal diagnosis in an admissions record (International Classification of Diseases 10th Edition Australian Modification (ICD-10-AM) code: I00--I02) \[[@B14-ijerph-17-05505]\]. A unique episode was defined as an ARF record \>90 days from the previous one and the earliest available diagnosis date was used to define episode onset \[[@B20-ijerph-17-05505],[@B21-ijerph-17-05505]\].

A person was defined to be an RHD case identified on an ARF/RHD register from the earliest date they had an RHD severity assessment evaluated as "mild", "moderate" or "severe" or had an RHD-related surgery or procedure recorded. Cases from the hospital data were defined from the earliest admission date where a predictive algorithm developed by the ERASE project assigned a predictive probability of being a valid RHD case. The prediction model considered ICD-10-AM codes I05--I09 as well as demographic and clinical variables \[[@B22-ijerph-17-05505],[@B23-ijerph-17-05505]\]. RHD was defined to be "severe" if an individual had a hospital discharge diagnosis of heart failure, a procedure code indicating a valvular procedure or surgery (see [Table A1](#ijerph-17-05505-t0A1){ref-type="table"} in the [Appendix A](#app1-ijerph-17-05505){ref-type="app"}) or was evaluated by a cardiologist as having severe RHD and documented on an ARF/RHD register accordingly.

The sample contains individuals 3--59 years of age at time of diagnosis. Individuals 60 years and over were excluded from the study, as this algorithm was not validated for this age group \[[@B17-ijerph-17-05505],[@B18-ijerph-17-05505]\]. Individuals under the age of three were excluded to reduce the risk of misclassification of congenital heart disease as RHD.

Other variables of interest included baseline demographic (age, sex, vital status, jurisdiction of residence, Accessibility/Remoteness Index of Australia (ARIA) distinguishing between "very remote", "remote", "outer regional", "inner regional" and "metropolitan" areas, socioeconomic status by population quintile (SES)), clinical (diagnosis (ARF or RHD), disease severity (mild/moderate or severe), ARF episode number (first-ever or recurrence), comorbidities and complications of RHD) and ARF/RHD register-related (last ARF/RHD diagnosis since register establishment) variables. The Socioeconomic Indexes for Areas (SEIFA) rank areas in Australia based on relative socio-economic advantage and disadvantage. For this study, Indigenous cases were allocated an Indigenous-specific socioeconomic index (Indigenous Relative Socioeconomic Outcomes index, IRSEO). The study used the most recent available recordings of SEIFA, IRSEO, ARIA, age and jurisdiction of residence for each individual. As comorbidity indices such as the Charlson Comorbidity Index \[[@B24-ijerph-17-05505]\] are not suitable for childhood conditions \[[@B25-ijerph-17-05505]\], individual comorbidities based on ICD-10-AM coded hospital admissions were investigated. The comorbidities included chronic obstructive pulmonary diseases, chronic kidney disease, other cardiovascular diseases, coronary heart disease, anticoagulant treatment, diabetes and mental health conditions. The complications considered for the analysis were heart failure, stroke, endocarditis and atrial fibrillation. Drugs/alcohol abuse and pregnancy (post-ARF/RHD diagnosis) were also investigated (see [Table A2](#ijerph-17-05505-t0A2){ref-type="table"} in the [Appendix A](#app1-ijerph-17-05505){ref-type="app"}).

2.2. Statistical Methods {#sec2dot2-ijerph-17-05505}
------------------------

[Figure 1](#ijerph-17-05505-f001){ref-type="fig"} provides a visual overview of the cohorts for each sub-analysis. Univariate comparisons of demographic, clinical and ARF/RHD register-related variables were conducted to describe the characteristics of cases identified through the two different sources of ARF/RHD records. We identified statistical significance at the 0.05 level using a two-sided Chi-squared test. To describe case ascertainment on the registers, we calculated the percentage of ARF/RHD patients identified in hospital administrative data who also had an ARF/RHD record on a register. We also calculated the percentage of diagnosis dates recorded on an ARF/RHD register that were the equal or prior to hospital admission dates to determine the agreement of case ascertainment systems regarding the earliest reliable indication of an ARF/RHD diagnosis of each case. Inferential analyses were conducted using multivariate logistic regression models. The outcome variable identified the source of the record (1 = hospital only, 0 = register only or both register and hospital). Model selection was based on a priori inclusion of important covariates (SES, age, sex, disease severity, jurisdiction) and a backward stepwise regression methodology. The final model excluded complications due to its collinearity with disease severity. All analyses were performed using RStudio (V1.1.463) RStudio PBC, Boston, MA., USA), and Microsoft Excel (Microsoft Corporation, Redmond, CA, USA).

3. Results {#sec3-ijerph-17-05505}
==========

3.1. Descriptive Analysis (Objective 1) {#sec3dot1-ijerph-17-05505}
---------------------------------------

Of the 7321 cases in either source ([Figure 2](#ijerph-17-05505-f002){ref-type="fig"}), 5824 were Indigenous (80%) ([Table 1](#ijerph-17-05505-t001){ref-type="table"}). Women comprised \~60% of cases for all data sources for both Indigenous and non-Indigenous patients. The cases only found in the hospital data had a higher percentage of individuals with 'RHD only' diagnoses, comorbidities, complications and a history of drugs/alcohol abuse compared with those only recorded on a register (all *p* \< 0.001). Hospital cases were also older (*p* \< 0.001), with \>60% being 35 years or older among Indigenous patients and \>60% being 45 years or older for non-Indigenous patients. This compares with 47% being 24 years or younger and 56% being 34 years or younger for Indigenous and non-Indigenous register only cases. Non-Indigenous cases had more than double the proportion of individuals appearing in the hospital data only (76%) compared with Indigenous cases (31%).

### 3.1.1. Indigenous Cases {#sec3dot1dot1-ijerph-17-05505}

The NT was the primary jurisdiction of residence for Indigenous cases ([Table 1](#ijerph-17-05505-t001){ref-type="table"}). Across all case ascertainment systems, Indigenous cases were predominantly from remote areas and from areas with the lowest SES (all *p* \< 0.001). Cases from the two highest SES areas (Quintile I & II) were mostly found in the hospital data only. As social disadvantage increased, the proportion of individuals in the hospital data only appeared to decrease. There was little difference in the time of diagnosis relative to register establishment between cases only found in the hospital data and cases that were only register-recorded (40% versus 41% diagnosed within two years after register establishment, *p* \< 0.001). 23% of Indigenous people in the hospital data also have a death record and accounted for 62% of all deceased Indigenous cases ([Table 1](#ijerph-17-05505-t001){ref-type="table"}). The majority of SA cases appeared in the hospital data only (47%) whereas the NT had the highest proportion of individuals appearing in both data sources (likely also related to the fact that NT has the largest number of cases overall). The characteristics of the cases in the hospital data only were similar when stratified by jurisdiction (see [Table A3](#ijerph-17-05505-t0A3){ref-type="table"} in the [Appendix A](#app1-ijerph-17-05505){ref-type="app"}).

### 3.1.2. Non-Indigenous Cases {#sec3dot1dot2-ijerph-17-05505}

QLD was the primary jurisdiction of residence for non-Indigenous cases ([Table 1](#ijerph-17-05505-t001){ref-type="table"}). The cases appearing in the hospital data only were predominantly from the most socioeconomically advantaged areas, while cases appearing on both the register and hospital data or the register record only, predominantly resided in the most socioeconomically disadvantaged areas (*p* \< 0.001). Cases residing remotely or in more disadvantaged areas had the lowest proportion of individuals in the hospital data only ([Table 1](#ijerph-17-05505-t001){ref-type="table"}).

3.2. Case Ascertainment on ARF/RHD Registers (Objective 2) {#sec3dot2-ijerph-17-05505}
----------------------------------------------------------

For both Indigenous and non-Indigenous cases, the proportion of hospitalised ARF/RHD cases that were also recorded on a register was lower for RHD cases (45% Indigenous, 13% non-Indigenous) compared with ARF cases (75% Indigenous, 33% non-Indigenous) ([Table 2](#ijerph-17-05505-t002){ref-type="table"}).

### 3.2.1. Indigenous Cases {#sec3dot2dot1-ijerph-17-05505}

QLD had 68% of ARF cases appearing on the register, and SA had only 21% of Indigenous cases with RHD included on the register ([Table 2](#ijerph-17-05505-t002){ref-type="table"}). The Northern areas of Australia (NT Top End: 46%, QLD North: 55%, WA North: 63%) had a higher percentage value of RHD cases appearing on the register compared with the rest of the country (NT Central: 37%, QLD Other: 38%, WA Other: 30%, SA Other: 33%), and especially with metropolitan areas (QLD Metro: 35%, WA Metro: 14%, SA Metro: 13%) ([Figure 3](#ijerph-17-05505-f003){ref-type="fig"}).

### 3.2.2. Non-Indigenous Cases {#sec3dot2dot2-ijerph-17-05505}

Non-Indigenous patients across all jurisdictions had less than 50% of hospitalised ARF cases and less than 25% of hospitalised RHD cases on the register ([Table 2](#ijerph-17-05505-t002){ref-type="table"}).

3.3. Agreement between Recorded Diagnosis Dates (Objective 3) {#sec3dot3-ijerph-17-05505}
-------------------------------------------------------------

For both Indigenous and non-Indigenous cases, QLD and WA had \>90% agreement between ARF episode dates recorded on their registers and hospital data ([Table 3](#ijerph-17-05505-t003){ref-type="table"}). In contrast, for Indigenous cases, NT and SA had \<40% of ARF register episode dates on the registers agreeing with those found in hospital data and \<15% for non-Indigenous episodes. The agreement in dates for RHD was higher for non-Indigenous cases compared with Indigenous cases (66% versus 60% across all jurisdictions).

Mean and median difference between dates recorded on the registers and hospital data were more variable among jurisdictions for RHD (mean: 79--347 days, median: 4--74 days) compared with ARF (mean: 3--15 days, median: 2--14 days). We also conducted a sensitivity analysis where we considered a 14-day 'grace period' for ARF onset and a 90-day 'grace period' for RHD onset. Any dates falling within these time windows across data sources were still considered to be in agreement. The agreement was greater than 89% for ARF and 77% for RHD (see [Table A4](#ijerph-17-05505-t0A4){ref-type="table"} in the [Appendix A](#app1-ijerph-17-05505){ref-type="app"}).

3.4. Multivariate Inferential Analysis (Objective 4) {#sec3dot4-ijerph-17-05505}
----------------------------------------------------

Non-Indigenous cases had 3.1 times higher odds of appearing in the hospital data only (95% CI 2.4--3.9, *p* \< 0.001) after adjusting for age, sex, disease severity, vital status, jurisdiction, ARIA, SES, comorbidity, drugs/alcohol abuse and register establishment ([Table 4](#ijerph-17-05505-t004){ref-type="table"}). Older age, comorbidities, drugs/alcohol abuse and disease severity but not sex were determinants of register exclusion. As the age group of the cases increased the adjusted odds of appearing in the hospital data only increased considerably. After adjustment, as disease severity increased the odds of being in the hospital data only decreased. The adjusted odds ratios (AOR) were not statistically significant for ARIA, vital status, comorbidities and register establishment for non-Indigenous cases, and SES for Indigenous cases.

### 3.4.1. Indigenous Cases {#sec3dot4dot1-ijerph-17-05505}

Indigenous cases in the 55--75 age bracket had 22 times (95% CI 15--32, *p* \< 0.001) higher odds of appearing in the hospital data only compared with individuals in the 3--14 age bracket. Cases who were last diagnosed more than two years after register establishment had 2.9 times the odds of not appearing on the register (95% CI 2.2--3.9, *p* \< 0.001). When compared with cases from NT, cases residing in QLD had lower odds of being in the hospital data only (AOR: 0.77 95% CI: 0.62--0.96, *p* = 0.018). Those with comorbidities were 1.3 times more likely to appear in hospital records only (95% CI: 1.1--1.5, *p* = 0.011).

### 3.4.2. Non-Indigenous Cases {#sec3dot4dot2-ijerph-17-05505}

For non-Indigenous cases, those in the 55--75 age bracket had 31 times the odds of appearing in the hospital data only compared with those in the 3--14 age bracket (95% CI 14--72, *p* \< 0.001). Social disadvantage increased the odds of inclusion in the register with the most disadvantaged areas being associated with the highest odds of inclusion (AOR: 0.29, 95% CI 0.17--0.49, *p* \< 0.001). Compared with the NT, residence in SA, QLD or WA increased the odds of cases appearing in the hospital data only (varying AOR: 2.6--30, *p* \< 0.05).

4. Discussion {#sec4-ijerph-17-05505}
=============

Register-based ARF/RHD control programs are most useful when case ascertainment is high, and accurate, timely and complete information appears in the database \[[@B21-ijerph-17-05505],[@B26-ijerph-17-05505],[@B27-ijerph-17-05505]\]. This study presents the first quasi-national Australian analysis investigating case ascertainment of ARF and RHD cases through ARF/RHD registers and hospital records using linked administrative data. We found that no single source provides comprehensive case ascertainment by itself, with 31% and 26% of Indigenous and 76% and 10% of non-Indigenous cases missing from the register and hospital data respectively. Differences in patient characteristics captured through the two case ascertainment systems (particularly age, Indigenous status, disease severity and comorbidity profiles) highlight the potential for bias associated when only one data source is considered. Therefore, realistic epidemiological analyses and policy targets for ARF/RHD control cannot be developed using only hospital or register data, a limitation commonly faced in the previous literature. Analyses conducted using only hospital data will likely be biased towards older, comorbid cases with greater disease severity, residing in more metropolitan areas. If only register data is used, a bias towards a younger ARF/RHD population with lower disease severity and a lower socioeconomic profile would likely be incurred.

Twice as many ARF cases than RHD cases were found in both ARF/RHD register and hospital data. There was substantial variability between jurisdictions and regions in the reliability of case ascertainment through the ARF/RHD registers. The registers recorded proportionally more Indigenous cases from the Northern areas of Australia (NT Top End, QLD North, WA North) than non-Indigenous cases or individuals residing in other areas, especially metropolitan regions. The agreement between diagnosis dates across data sources also varied substantially by jurisdiction. For ARF, Queensland and WA performed substantially better than NT and SA.

We found that non-Indigenous status remains a significant predictor of being missed by the ARF/RHD registers of cases, after adjustment for age, sex, disease severity, vital status, jurisdiction, ARIA, SES, comorbidity, drugs/alcohol abuse and register establishment. Other significant determinants of exclusion from registers include older age, comorbidities, drugs/alcohol abuse and disease severity, but not sex.

Prior to this analysis, few studies have validated case ascertainment on ARF/RHD registers. Two Australian studies reported results on case ascertainment on the WA and NT ARF/RHD registers as incidental findings, rather than the primary study goal. In those small, regional studies, the WA and NT ARF/RHD registers were found to be incomplete (NT: 19% incomplete; Kimberley region of WA: 27% incomplete) \[[@B21-ijerph-17-05505],[@B26-ijerph-17-05505]\] and containing errors due to the manual data entry process \[[@B13-ijerph-17-05505]\]. Studies in Fiji and New Zealand have also found gaps in case ascertainment on ARF/RHD registers \[[@B20-ijerph-17-05505],[@B28-ijerph-17-05505]\].

The disparities between population groups and jurisdictions in case ascertainment observed in this study can be attributed to policy differences and operational considerations. All jurisdictions apart from SA, introduced ARF notification before the development of ARF/RHD disease registers, with rheumatic heart disease only becoming notifiable more recently. In SA, delayed notification requirements for ARF/RHD (in 2016 four years after the establishment of the ARF/RHD register) may have contributed to the lowest proportion of register notifications observed in this study. All jurisdictional registers mainly employ passive surveillance with the registration process relying on clinicians and health service providers being aware of ARF/RHD and their knowledge of having to complete notification forms \[[@B10-ijerph-17-05505]\]. Case ascertainment through the ARF/RHD register may be improved by more automated notification processes and standardised protocols for data entry; this would also reduce the labour-intensive need for manual data handling by the registers and the associated risks for data quality.

However, notification requirements can be complemented by other policies to increase case ascertainment. Outside of the NT, QLD had the highest proportion of hospitalised RHD cases recorded on its ARF/RHD register compared to the other jurisdictions despite RHD becoming notifiable outside of our research study period for this jurisdiction (2018). This may be related to comprehensive active case finding work in QLD that commenced in 2014 and identified 500 ARF/RHD cases previously unknown to the register \[[@B29-ijerph-17-05505]\], highlighting the importance of this approach to case ascertainment as part of control programs.

Operationally, the ARF/RHD registers face challenges such as limitations in resourcing with regard to infrastructure and staff. These operational constraints necessitate focusing on population groups and geographical areas where active case finding will likely identify a relatively large number of cases. It seems likely that such practical and clinically pertinent considerations have influenced the large representation of younger, Indigenous and Northern Australian cases recorded on ARF/RHD registers.

Patient transfers and low clinical awareness of ARF and RHD may have also lowered the case ascertainment by registers \[[@B10-ijerph-17-05505]\]. We found that metropolitan areas (generally better-resourced) had a relatively lower proportion of ARF/RHD patients on the registers compared with the rest of Australia (generally less-resourced). This suggests a need to increase clinical awareness and education of health service providers across Australia about ARF/RHD and notification requirements, including in metropolitan areas. The observed limitations in case ascertainment on the ARF/RHD registers and their likely causes point to the benefits of establishing a central, national ARF/RHD register based on automated notification and data management processes to achieve both more accurate epidemiological monitoring and more consistent real-time patient care including those across jurisdictional boundaries. Conversely, not all register recorded cases were found in the hospital data either. Despite guidelines recommending the hospitalisation of ARF patients \[[@B10-ijerph-17-05505]\], one-quarter (710 cases) of Indigenous ARF cases appeared in the register records only. As suggested by Artuso et al. \[[@B30-ijerph-17-05505]\], these cases were likely notified by primary health care services without hospitalisation due to a range of factors known to affect hospital utilisation by Indigenous patients including escort ineligibility/ availability, competing family priorities and mistrust of the health system.

For both case ascertainment methods, ARF/RHD register and hospital data, some cases may have been missed for various reasons. Sub-clinical ARF cases were likely under-represented due to a presumed high number of subclinical cases not seeking medical care, unavailability of primary health care data, underdiagnosis due to limited knowledge of ARF by clinicians and the clinical complexity associated with making an ARF diagnosis, including the lack of a definitive diagnostic test \[[@B10-ijerph-17-05505],[@B31-ijerph-17-05505]\]. Miscoding in the hospital data (resulting in cases not being identified as ARF/RHD) and the limited study period may have also contributed to incomplete case ascertainment. Additionally, this study did not investigate case ascertainment for individuals last hospitalised for ARF/RHD before register establishment in their jurisdiction of residence, because the ARF/RHD registers do not generally engage in retrospective case finding. Current privacy limitations in cross-jurisdictional data linkage outside of SA and NT limited the tracking of patients across jurisdictions. It would be beneficial for a future study to investigate the characteristics of cases in primary health care services, as this data was not systematically available for this analysis. Small sample sizes, particularly among non-Indigenous cases, may have caused noise in the data and affected the power of the regression analysis. Furthermore, compared with cases appearing in the hospital data, our ability to describe the characteristics of the register-only cases was limited by the lack of recording of patient information relating to, for example, comorbidities, SES and remoteness. NSW was not included in our analysis, because its ARF/RHD register was only established at the end of 2016.

5. Conclusions {#sec5-ijerph-17-05505}
==============

The NT, SA, QLD and WA ARF/RHD registers are part of the national Rheumatic Fever Strategy for control programs. Besides their surveillance function, an important goal of the register-based programs is to strengthen the prevention of ARF recurrences and minimise RHD progression by supporting the regular provision of secondary prophylaxis \[[@B13-ijerph-17-05505]\]. The effectiveness of the control programs is affected by incomplete case ascertainment. Pertinently, younger, Indigenous and Northern Australian cases are more comprehensively represented on ARF/RHD registers. However, differences in the characteristics of ARF/RHD cases across administrative hospital records and ARF/RHD registers demonstrate the need to utilise multiple sources when investigating the epidemiology of ARF/RHD in Australia to minimise systematic biases. Increased awareness of ARF/RHD in general and specifically of the notification requirements amongst clinicians would improve case ascertainment under the current operational systems. Furthermore, moving towards more integrated and automated systems, ideally implemented as a central, national ARF/RHD register, has the potential to improve communication and cooperation between the registers and health care services, minimise the workload of clinicians and the double handling of data and thus increase case ascertainment and data accuracy. This study demonstrates the need for sophisticated monitoring and surveillance systems in the global effort to reduce the burden of ARF and RHD.
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###### 

ICD-AM-10 codes for procedures and surgeries related to RHD.

  Classification        ICD-10-AM Codes
  --------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  RHD Procedure Codes   3827001--3827003, 9622200, 3848808--3848811
  RHD Surgery Codes     3845610, 3848300, 3848000, 3848100, 3848800, 3848801, 3848900, 3848901, 3845615, 3865304, 3848700, 3848501, 3848001, 3848101, 3847500, 3847700, 3848802, 3848803, 3848902, 3848500, 3845616, 3865305, 3845611, 3848002, 3848102, 3847501, 3847701, 3848804, 3848805, 3848903, 3845617, 3865306, 3845601, 3848806, 3848807, 3848904, 3848905, 3845618, 3865307, 3847502, 3847702

ijerph-17-05505-t0A2_Table A2

###### 

ICD-10-AM codes for comorbidities of ARF and RHD.

  Condition                               ICD-10-AM Codes
  --------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------
                                          *Comorbiditie*
  Chronic Obstructive Pulmonary Disease   J40 - J47
  Chronic Kidney Disease                  E10.2, E11.2, E12.2, E13.2, E14.2, I15.0, I15.1, N39.1, N39.2, T82.4, Z94.0, Z99.2, I12, I13, N00 - N08, N11--N12, N14--N16, N18, N19, N25--N28, Q60--Q63, Z49
  Other Cardiovascular Diseases           I10 -I11, I15.2, I15.8, I15.9, I20 - I28, I30--I32, I34--I47, I49, I51, I52, I65-I89, I95--I99
  Coronary Heart Disease                  I20--I25
  Anticoagulant                           D62, D68.3, D68.4, D68.8
  Diabetes                                E10--E14
  Mental Health Conditions                F202013F99
                                          *Complications*
  Stroke                                  I60--I64
  Heart Failure                           I50
  Atrial Fibrillation                     I48
  Endocarditis                            I33
                                          *Drug/Alcohol Abuse*
  Alcohol Abuse                           JZ50.2, Z71.4, Z72.1, F10, K70, E24.4, G31.2, G62.1, G72.1, I42.6, K29.2, K86.0, O35.4, T51.9
  Tobacco Smoking                         Z71.6, Z72.0, F17, T65.2
  Drug abuse                              Z71.5, F11 - F19, R78.1, R78.2, R78.3, R78.4, R78.5, T40, Y12, Z50.3, O35.5
                                          *Pregnancy*
  Pregnancy                               O00 - O48, O60, O61-O77, O80-O82, O85-O92, O94, O9A, O98, O99, Z34, Z3A, F53, A34, E23, M83.0

ijerph-17-05505-t0A3_Table A3

###### 

Descriptive analysis of the study samples, stratified by jurisdiction.

  Variable                                              Indigenous (*n* = 1821)                                                                                                    
  ----------------------------------------------------- ------------------------- --------------- ----------------- ---------------- ------ ------ ----- ------ ----- ----- ------ -----
  Total                                                 1207                      100%            36%               54               100%   47%    380   100%   24%   180   100%   23%
  Most Recent Age (years)                                                                                                                                                          
  3--14                                                 39                        3%              9%                \<5              4%     9%     49    13%    16%   17    9%     12%
  15--24                                                78                        6%              11%               5                9%     24%    50    13%    13%   26    14%    13%
  25--34                                                189                       16%             27%               12               22%    55%    58    15%    19%   35    19%    20%
  35--44                                                341                       28%             55%               9                17%    64%    55    14%    26%   36    20%    28%
  45--54                                                291                       24%             59%               8                15%    57%    94    25%    47%   31    17%    37%
  55--75                                                268                       22%             65%               18               33%    78%    72    19%    50%   35    19%    61%
  Sex                                                                                                                                                                              
  Male                                                  427                       35%             33%               20               37%    50%    154   41%    25%   52    29%    19%
  Female                                                780                       65%             37%               34               63%    45%    226   59%    24%   128   71%    25%
  Diagnosis                                                                                                                                                                        
  ARF Only                                              143                       12%             19%               5                9%     23%    95    25%    30%   41    23%    20%
  RHD Only                                              998                       83%             56%               48               89%    61%    277   73%    31%   134   74%    36%
  Both                                                  66                        5%              8%                \<5              2%     7%     8     2%     2%    5     3%     3%
  RHD Severity                                                                                                                                                                     
  Severe RHD                                            479                       40%             43%               35               65%    71%    160   42%    34%   91    51%    33%
  Mild/ Moderate RHD                                    585                       48%             39%               14               26%    31%    125   33%    16%   48    27%    16%
  ARF Only                                              143                       12%             19%               5                9%     23%    95    25%    30%   41    23%    20%
  ARF Recurrence                                                                                                                                                                   
  Total ARF Cases                                       209                       17%             13%               6                11%    16%    103   27%    15%   46    25%    12%
  No Recurrence                                         170                       81%             14%               5                83%    14%    99    96%    17%   39    85%    12%
  Recurrence                                            39                        19%             12%               \<5              17%    100%   \<5   4%     5%    7     15%    9%
  Indigenous (*n* = 1821)                                                                                                                                                          
                                                        NT (*n* = 1207)           SA (*n* = 54)   QLD (*n* = 380)   WA (*n* = 180)                                                 
  Variable                                              *n*                       C%              R%                *n*              *C%*   R%     *n*   C%     R%    *n*   C%     R%
  Vital Status                                                                                                                                                                     
  Alive                                                 882                       73%             31%               49               91%    42%    317   83%    22%   155   86%    21%
  Dead                                                  325                       27%             62%               5                9%     71%    63    17%    66%   25    14%    56%
  Remoteness (ARIA)                                                                                                                                                                
  Inner Regional                                        \<5                       0%              100%              24               44%    73%    75    20%    49%   62    34%    53%
  Outer Regional                                        165                       14%             49%               19               35%    59%    135   36%    24%   22    12%    43%
  Remote                                                1028                      85%             36%               9                17%    39%    170   45%    21%   96    53%    16%
  SES                                                                                                                                                                              
  Quintile I & II                                       124                       10%             48%               18               33%    95%    59    16%    34%   44    24%    32%
  Quintile III                                          111                       9%              51%               7                13%    54%    137   36%    27%   27    15%    51%
  Quintile IV                                           136                       11%             42%               23               43%    50%    113   30%    25%   64    36%    24%
  Quintile V                                            825                       68%             34%               \<5              7%     40%    71    19%    20%   45    25%    15%
  Last Diagnosis Since Register Establishment (years)                                                                                                                              
  Mean Time                                             8.3                                                         2.1                            4.0                2.7          
  0--\<2                                                93                        8%              74%               19               35%    59%    69    18%    24%   57    32%    37%
  2+                                                    1114                      92%             34%               35               65%    42%    311   82%    24%   123   68%    20%
  Comorbidity                                                                                                                                                                      
  Any Comorbidity                                       916                       76%             50%               44               81%    75%    245   64%    34%   130   72%    34%
  Chronic Obstructive Pulmonary Diseases                239                       20%             59%               11               20%    85%    49    13%    51%   37    21%    44%
  Chronic Kidney Disease                                454                       38%             61%               13               24%    76%    100   26%    48%   51    28%    43%
  Other Cardiovascular Diseases                         788                       65%             52%               35               65%    78%    216   57%    38%   111   62%    38%
  Coronary Heart Diseases                               364                       30%             66%               12               22%    71%    102   27%    65%   45    25%    67%
  Anticoagulant                                         229                       19%             61%               11               20%    85%    49    13%    46%   41    23%    41%
  Diabetes                                              485                       40%             62%               17               31%    74%    126   33%    44%   64    36%    44%
  Mental Health Conditions                              109                       9%              53%               15               28%    83%    49    13%    39%   30    17%    35%
  Indigenous (*n* = 1,821)                                                                                                                                                         
                                                        NT (*n* = 1,207)          SA (*n* = 54)   QLD (*n* = 380)   WA (*n* = 180)                                                 
  Variable                                              *n*                       C%              R%                *n*              C%     R%     *n*   C%     R%    *n*   C%     R%
  Complications                                                                                                                                                                    
  Any Complication                                      496                       41%             57%               33               61%    85%    154   41%    46%   86    48%    46%
  Stroke                                                50                        4%              58%               \<5              6%     100%   17    4%     49%   8     4%     35%
  Heart Failure                                         368                       30%             58%               25               46%    83%    113   30%    50%   72    40%    51%
  Atrial Fibrillation                                   278                       23%             56%               19               35%    83%    94    25%    43%   55    31%    47%
  Endocarditis                                          38                        3%              54%               \<5              7%     100%   21    6%     58%   10    6%     43%
  Drug/Alcohol Abuse                                                                                                                                                               
  Any Substance                                         834                       69%             49%               40               74%    74%    244   64%    34%   122   68%    30%
  Alcohol Abuse                                         463                       38%             54%               23               43%    72%    107   28%    38%   56    31%    28%
  Drug Abuse                                            56                        5%              47%               8                15%    73%    33    9%     38%   24    13%    36%
  Tobacco Smoking                                       756                       63%             49%               36               67%    72%    232   61%    34%   116   64%    30%
  Pregnancy                                                                                                                                                                        
  Females of Reproductive Age                           507                       42%             34%               24               44%    51%    133   35%    21%   83    46%    24%
  Pregnancy                                             234                       46%             39%               10               42%    67%    57    43%    25%   31    37%    27%

ijerph-17-05505-t0A4_Table A4

###### 

Sensitivity analysis on the agreement between recorded diagnosis dates based on a 14-day grace period for ARF episodes and a 90-day grace period for RHD diagnosis by Indigenous status, jurisdiction and Indigenous regions.

  Indigenous Status            ARF          RHD                                                                     
  ---------------------------- ------------ ------ ------ ----- ---- ---- ------ ------ ------ ------ ------ ------ -----
  Jurisdiction                 NT           979    944    96%   38   30   41     881    765    87%    982    718    992
  SA                           19           17     89%    20    20   2    14     12     86%    400    400    269    
  QLD                          279          275    99%    28    28   4    319    246    77%    692    497    727    
  WA                           186          185    99%    17    17   0    131    115    88%    581    495    528    
  Total                        1463         1421   97%    35    28   27   1345   1138   85%    843    594    893    
  Indigenous Regions (IREGs)   NT Top End   733    712    97%   44   33   33     666    583    88%    919    727    995
  NT Central                   246          232    94%    27    17   8    215    182    85%    1140   612    1031   
  SA Other                     13           12     92%    22    22   0    9      8      89%    131    131    0      
  SA Metro                     6            5      83%    18    18   0    5      \<5    80%    668    668    0      
  QLD North                    244          241    99%    29    28   7    273    210    77%    687    385    747    
  QLD Other                    23           23     100%                   21     18     86%    1205   1267   642    
  QLD Metro                    12           11     92%    27    27   0    25     18     72%    523    530    118    
  WA North                     135          134    99%    17    17   0    105    95     90%    600    495    471    
  WA Other                     32           32     100%                   18     12     67%    550    450    551    
  WA Metro                     19           19     100%                   8      8      100%                        
  Non-Indigenous                                                                                                    
  Jurisdiction                 NT           13     12     92%   23   23   0      19     16     84%    492    452    407
  SA                           \<5          \<5    100%                   7      6      86%    232    232    0      
  QLD                          58           57     98%    25    25   0    116    104    90%    772    466    1190   
  WA                           \<5          \<5    100%                   \<5    \<5    100%                        
  Total                        76           74     97%    24    24   1    143    127    89%    686    434    968    

![Study objectives and sub-samples.](ijerph-17-05505-g001){#ijerph-17-05505-f001}

![Flowchart of sample selection.](ijerph-17-05505-g002){#ijerph-17-05505-f002}

![Percentage of hospital diagnosed acute rheumatic fever (ARF) and rheumatic heart disease (RHD) cases recorded on ARF/RHD registers for Indigenous cases by jurisdiction and geography.](ijerph-17-05505-g003){#ijerph-17-05505-f003}

ijerph-17-05505-t001_Table 1

###### 

Descriptive analysis of the study samples by Indigenous status and data sources.

  Variable                                                Indigenous (*n* = 5824)         Non--Indigenous (*n* = 1497)                                                                     
  ------------------------------------------------------- ------------------------- ----- ------------------------------ ----- ------ ----- --------- ------ ----- ----- ----- ----- ----- ---------
  Total                                                   1821                      31%   2484                           43%   1519   26%             1135   76%   206   14%   156   10%   
  Most Recent Age (years)                                 \<0.001                         \<0.001                                                                                          
  3--14                                                   107                       12%   535                            59%   261    29%             35     38%   32    35%   24    26%   
  15--24                                                  159                       12%   720                            54%   457    34%             50     36%   46    33%   42    30%   
  25--34                                                  294                       25%   548                            46%   344    29%             90     67%   23    17%   22    16%   
  35--44                                                  441                       46%   319                            33%   209    22%             149    78%   28    15%   15    8%    
  45--54                                                  424                       54%   225                            28%   141    18%             262    83%   36    11%   18    6%    
  55--75                                                  393                       62%   137                            22%   107    17%             511    87%   41    7%    35    6%    
  Sex                                                     0.153                           0.725                                                                                            
  Male                                                    653                       30%   944                            43%   592    27%             443    75%   80    14%   66    11%   
  Female                                                  1168                      32%   1539                           42%   927    26%             692    76%   126   14%   90    10%   
  Diagnosis                                               \<0.001                         \<0.001                                                                                          
  ARF Only                                                284                       22%   551                            42%   463    36%             142    71%   28    14%   29    15%   
  RHD Only                                                1457                      47%   856                            27%   809    26%             985    81%   119   10%   108   9%    
  Both                                                    80                        6%    1077                           77%   247    18%             8      9%    59    69%   19    22%   
  Disease Status                                          \<0.001                         \<0.001                                                                                          
  Severe RHD                                              765                       40%   911                            48%   226    12%             740    80%   133   14%   48    5%    
  Non-Severe RHD                                          772                       29%   1022                           39%   830    32%             253    67%   45    12%   79    21%   
  ARF Only                                                284                       22%   551                            42%   463    36%             142    71%   28    14%   29    15%   
  ARF Recurrence                                          \<0.001                         0.122                                                                                            
  Total                                                   365                       14%   1628                           60%   710    26%             150    53%   87    31%   48    17%   
  No                                                      313                       14%   1222                           55%   668    30%             145    53%   81    30%   48    18%   
  Yes                                                     51                        10%   406                            81%   42     8%              5      45%   6     55%   0     0%    
  Vital Status                                            \<0.001                         0.056                                                                                            
  Alive                                                   1403                      27%   2264                           44%   1483   29%             1023   75%   193   14%   148   11%   
  Dead                                                    418                       62%   220                            33%   36     5%              112    84%   13    10%   8     6%    
  State of Residence                                      \<0.001                         \<0.001                                                                                          
  NT                                                      1207                      36%   1580                           47%   591    17%             81     52%   31    20%   43    28%   
  SA                                                      54                        47%   33                             28%   29     25%             135    91%   8     5%    6     4%    
  QLD                                                     380                       24%   585                            38%   593    38%             705    73%   163   17%   101   10%   
  WA                                                      180                       23%   286                            37%   306    40%             214    96%   \<5   2%    6     3%    
  Remoteness (ARIA)                                       \<0.001                         \<0.001                                                                                          
  Inner regional                                          164                       54%   91                             30%   50     16%             867    82%   136   13%   53    5%    
  Outer Regional                                          341                       35%   407                            41%   235    24%             190    71%   49    18%   29    11%   
  Remote                                                  1303                      31%   1982                           47%   975    23%             55     59%   19    20%   20    21%   
  Socioeconomic Status (SES)                              \<0.001                         \<0.001                                                                                          
  Quintile I & II                                         245                       42%   202                            34%   141    24%             362    87%   31    7%    25    6%    
  Quintile III                                            282                       35%   343                            43%   176    22%             248    78%   49    15%   21    7%    
  Quintile IV                                             336                       31%   442                            40%   317    29%             221    79%   38    14%   19    7%    
  Quintile V                                              945                       31%   1493                           49%   626    20%             283    70%   86    21%   36    9%    
  Last Interaction Since Register Establishment (years)   \<0.001                         \<0.001                                                                                          
  Mean Time                                               6.7                             9.6                                  6.3                    3.5          5.3         5.5         
  0--2                                                    238                       40%   113                            19%   247    41%             295    84%   34    10%   21    6%    
  2+                                                      1583                      30%   2371                           45%   1272   24%             840    73%   172   15%   135   12%   
  Comorbidity                                                                                                                                                                              
  Any                                                     1335                      44%   1268                           42%   415    14%   \<0.001   873    84%   128   12%   38    4%    \<0.001
  Complications                                                                                                                                                                            
  Any                                                     769                       54%   570                            40%   93     6%    \<0.001   601    85%   85    12%   22    3%    \<0.001
  Drug/Alcohol Abuse                                                                                                                                                                       
  Any Substance                                           1240                      43%   1124                           39%   527    18%   \<0.001   414    84%   51    10%   28    6%    \<0.001
  Pregnancy                                                                                                                                                                                
  Females of Reproductive Age                             747                       30%   1095                           43%   679    27%   \<0.001   250    70%   64    18%   45    13%   0.004
  Pregnancy                                               332                       35%   480                            50%   144    15%   \<0.001   68     74%   15    16%   9     10%   0.540

ijerph-17-05505-t002_Table 2

###### 

Count and percentage of hospital diagnosed ARF/RHD cases recorded on ARF/RHD registers by Indigenous status and jurisdiction.

  Indigenous Status             ARF    RHD                              
  ----------------------------- ------ ------ ----- ------ ------ ----- -----
  Indigenous                                                            
  Jurisdiction                  NT     1133   874   77%    2029   881   43%
  SA                            25     19     76%   66     14     21%   
  QLD                           414    280    68%   622    319    51%   
  WA                            226    172    76%   283    131    46%   
  Total                         1798   1345   75%   3000   1345   45%   
  Non-Indigenous                                                        
  Jurisdiction                  NT     30     13    43%    87     19    22%
  SA                            8      \<5    12%   135    7      5%    
  QLD                           167    59     35%   721    116    16%   
  WA                            27     \<5    15%   193    \<5    1%    
  Total                         232    77     33%   1136   143    13%   
  Indigenous & non-Indigenous   2030   1422   70%   4136   1488   36%   

ijerph-17-05505-t003_Table 3

###### 

Agreement between recorded diagnosis dates for ARF and RHD cases on both sources by Indigenous status, jurisdiction and Indigenous region.

  Indigenous Status            ARF          RHD                                                                 
  ---------------------------- ------------ ----- ------ ----- ---- ---- ------ ----- ------ ----- ----- ------ -----
  Jurisdiction                 NT           979   396    40%   6    3    5      881   548    62%   347   8      324
  SA                           19           6     32%    6     4    6    14     5     36%    92    5     5      
  QLD                          279          268   96%    15    14   22   319    163   51%    331   56    445    
  WA                           186          174   94%    3     2    2    131    93    71%    258   59    262    
  Total                        1463         844   58%    6     3    5    1345   809   60%    332   16    348    
  Indigenous Regions (IREGs)   NT Top End   733   306    42%   5    2    4      666   405    61%   298   6      187
  NT Central                   246          90    37%    7     5    7    215    143   67%    526   17    609    
  SA Other                     13           \<5   31%    7     5    5    9      \<5   33%    24    3     3      
  SA Metro                     6            \<5   33%    6     2    5    5      \<5   40%    227   7     331    
  QLD North                    244          235   96%    15    14   18   273    133   49%    317   49    334    
  QLD Other                    23           22    96%    1     1    0    21     16    76%    724   532   1262   
  QLD Metro                    12           11    92%    27    27   0    25     14    56%    336   439   531    
  WA North                     135          130   96%    5     3    3    105    77    73%    231   54    226    
  WA Other                     32           28    88%    1     1    0    18     9     50%    372   218   580    
  WA Metro                     19           16    84%    2     2    1    8      7     88%    1     1     0      
  Non-Indigenous                                                                                                
  Jurisdiction                 NT           13    \<5    15%   7    5    7      19    13     68%   254   74     350
  SA                           \<5          0     0%     6     6    0    7      \<5   57%    79    4     116    
  QLD                          58           56    97%    14    14   12   116    76    66%    239   6     141    
  WA                           \<5          \<5   100%                   \<5    \<5   100%                      
  Total                        76           62    82%    8     6    7    143    94    66%    231   7     146    

ijerph-17-05505-t004_Table 4

###### 

Multivariate inferential analysis of ARF and RHD cases only found in the hospital data.

  Variable                                              Total (*n* = 5565)   Indigenous (*n* = 4284)   Non-Indigenous (*n* = 1281)                                                                                                                              
  ----------------------------------------------------- -------------------- ------------------------- ----------------------------- -------------- --------- ------ -------------- ------ -------------- --------- ------ -------------- ------ -------------- ---------
  Indigenous status                                                                                                                                                                                                                                             
  Non-Indigenous                                        7.3                  (6.2--8.5)                3.1                           (2.4--3.9)     \<0.001                                                                                                     
  Most Recent Age (years)                                                                                                                                                                                                                                       
  15--24                                                1.1                  (0.85--1.4)               1.2                           (0.89--1.5)    0.267     1.1    (0.84--1.4)    1.2    (0.86--1.5)    0.347     1.0    (0.53--1.9)    1.2    (0.55--2.5)    0.691
  25--34                                                2.7                  (2.1--3.3)                3.8                           (2.9--5.1)     \<0.001   2.7    (2.1--3.4)     3.5    (2.5--4.8)     \<0.001   3.6    (1.8--7.0)     7.6    (3.3--18)      \<0.001
  35--44                                                6.8                  (5.4--8.5)                10                            (7.4--14)      \<0.001   6.9    (5.4--8.9)     9.7    (7.0--14)      \<0.001   4.8    (2.6--9.2)     9.1    (4.0--22)      \<0.001
  45--54                                                11                   (8.4--13)                 14                            (11--20)       \<0.001   9.4    (7.3--12)      14     (10--20)       \<0.001   6.8    (3.7--12)      16     (7.0--38)      \<0.001
  55--75                                                21                   (16--26)                  23                            (17--32)       \<0.001   14     (11--19)       22     (15--32)       \<0.001   12     (6.7--21)      31     (14--72)       \<0.001
  Sex                                                                                                                                                                                                                                                           
  Male                                                  0.95                 (0.85--1.1)               1.1                           (0.97--1.3)    0.125     0.90   (0.79--1.0)    1.1    (0.93--1.3)    0.300     1.0    (0.75--1.4)    1.2    (0.86--1.8)    0.256
  Disease Status                                                                                                                                                                                                                                                
  Severe RHD                                            1.9                  (1.7--2.2)                0.18                          (0.14--0.23)   \<0.001   1.6    (1.4--1.9)     0.20   (0.15--0.26)   \<0.001   1.1    (0.68--1.7)    0.08   (0.04--0.17)   \<0.001
  Mild/Moderate RHD                                     1.3                  (1.1--1.5)                0.45                          (0.37--0.56)   \<0.001   1.5    (1.2--1.7)     0.49   (0.39--0.61)   \<0.001   1.1    (0.64--1.8)    0.22   (0.11--0.44)   \<0.001
  Vital Status                                                                                                                                                                                                                                                  
  Dead                                                  2.4                  (2.0--2.8)                1.8                           (1.5--2.3)     \<0.001   3.1    (2.6--3.7)     1.8    (1.5--2.3)     \<0.001   1.7    (0.97--3.2)    1.2    (0.62--2.4)    0.619
  State of Residence                                                                                                                                                                                                                                            
  SA                                                    5.7                  (4.1--8.1)                2.1                           (1.3--3.3)     0.002     2.1    (1.3--3.3)     1.6    (0.92--2.8)    0.097     6.6    (3.0--16)      8.9    (3.4--25)      \<0.001
  QLD                                                   1.8                  (1.6--2.0)                0.87                          (0.7--1.0)     0.131     0.85   (0.73--0.99)   0.77   (0.62--0.96)   0.018     1.6    (1.0--2.6)     2.6    (1.4--5.0)     0.004
  WA                                                    1.7                  (1.4--2.0)                1.1                           (0.87--1.4)    0.421     0.83   (0.68--1.0)    0.81   (0.62--1.1)    0.110     21     (8.1--73)      30     (9.7--118)     \<0.001
  Last Diagnosis Since Register Establishment (years)                                                                                                                                                                                                           
  2+                                                    3.8                  (3.2--4.6)                2.3                           (1.9--3.0)     \<0.001   3.2    (2.5--4.0)     2.9    (2.2--3.9)     \<0.001   1.8    (1.2--2.7)     1.2    (0.74--1.8)    0.529
  Comorbidity                                                                                                                                                                                                                                                   
  yes                                                   2.7                  (2.4--3.0)                1.3                           (1.1--1.5)     0.008     2.6    (2.3--3.0)     1.3    (1.1--1.5)     0.011     2.0    (1.5--2.7)     1.6    (0.97--2.5)    0.061
  Drug/Alcohol Abuse                                                                                                                                                                                                                                            
  yes                                                   1.7                  (1.5--1.9)                1.3                           (1.1--1.5)     0.001     2.6    (2.3--3.0)     1.3    (1.1--1.5)     0.004     1.8    (1.3--2.6)     1.6    (1.1--2.4)     0.029
  Remoteness (ARIA)                                                                                                                                                                                                                                             
  Inner Regional                                        6.5                  (5.5--7.6)                2.1                           (1.6--2.8)     \<0.001   2.7    (2.1--3.6)     2.5    (1.7--3.7)     \<0.001   2.1    (1.2--3.6)     1.1    (0.48--2.3)    0.863
  Outer Regional                                        1.7                  (1.5--2.0)                1.0                           (0.9--1.3)     0.736     1.3    (1.1--1.5)     1.1    (0.85--1.4)    0.515     1.3    (0.71--2.4)    0.82   (0.38--1.7)    0.600
  Socioeconomic Status                                                                                                                                                                                                                                          
  Quintile III                                          0.41                 (0.33--0.52)              0.71                          (0.53--0.95)   0.022     0.68   (0.53--0.87)   1.1    (0.83--1.5)    0.465     0.42   (0.26--0.68)   0.44   (0.25--0.76)   0.003
  Quintile IV                                           0.51                 (0.40--0.66)              0.75                          (0.55--1.0)    0.061     0.63   (0.5--0.79)    1.1    (0.80--1.5)    0.521     0.52   (0.31--0.85)   0.45   (0.25--0.79)   0.006
  Quintile V                                            0.23                 (0.19--0.28)              0.58                          (0.44--0.75)   \<0.001   0.52   (0.43--0.64)   0.86   (0.64--1.2)    0.344     0.28   (0.18--0.43)   0.29   (0.17--0.49)   \<0.001
